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Abstract 
Background and Purpose: Intracerebral Hemorrhage (ICH) has a poorer prognosis than 
acute ischemic stroke (AIS). However, clinician perception of prognosis may influence 
treatment decisions and adversely affect outcome. On acute CT, the conspicuity of ICH 
compared to AIS may lead clinicians to overestimate severity and influence prognostic 
evaluation. We investigated whether clinicians’ estimates of volume, severity and prognosis 
from acute imaging differed between ICH and AIS.  
 
Methods: CT scans from participants with acute ICH or ischemic stroke were reviewed. 
Volume was calculated using the ABC/2 method and automated volumetric analysis via 
specialised imaging software. ICH cases were matched with AIS cases for lesion volume, 
based on acute (<6h) CT for ICH, and 24h CT for AIS. Blind to clinical information, 
clinicians estimated lesion volume to the nearest 5ml, graded lesion severity from 1 (mild) to 
5 (very severe) and estimated 30-day prognosis using the modified Rankin Scale (mRS).  
 
Results: We compared 33 ICH cases with 33 volume-matched AIS cases. Clinicians 
overestimated ICH volume and underestimated AIS volumes: mean differences (estimated - 
actual volume) were +8ml (±30) for ICH and -8ml (±27) for AIS (p<0.001). Observers rated 
ICH to be of greater severity and poorer prognosis compared to AIS cases: 109/265 [41%] 
ICH cases rated severity categories 4 or 5 compared to 36/257 [14%] AIS, p<0.001; 
estimated mRS 0-2 in 125/265 [47%] of ICH compared to 190/257 [74%] AIS, p<0.001. 
Results were unaffected by presence of intraventricular blood. Estimated severity and 
prognosis for ICH remained significantly worse compared to AIS after adjustment for 
estimated volumes.  
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Conclusions: Clinicians overestimated ICH volume and severity compared to AIS of 
equivalent volume, and also assigned significantly worse prognosis independent of volume 
estimates. 
 
 
Background 
Intracerebral hemorrhage (ICH) has a poorer prognosis than acute ischemic stroke (AIS).  
One month mortality following ICH is estimated to be approximately 40%, around four times 
that seen in AIS [1-3]. Long term outcomes are comparably poor: survival following ICH is 
46% at one year, with 75% either deceased or severely disabled [ 4].  
 
A negative perception of prognosis may, however, impact significantly on the management 
of patients with ICH. Clinical underestimation of the chances of favorable outcome in severe 
ICH cases may prompt clinicians to limit intensive management strategies [5, 6] and lead to 
early implementation of end-of-life protocols, with the inevitable consequence of higher 
mortality among these patients [7]. Prognosis may therefore be biased as a consequence of 
clinical perception. However, Clinician assessment of prognosis has been shown to more 
closely predict 3-month outcome ICH than prognostic scales [8]. 
 
Despite the differences in outcomes between ICH and AIS, previous studies have reported 
that stroke type did not influence prognosis when lesion volume and initial severity of 
symptoms were accounted for [9]. Greater average lesion volume in ICH compared to AIS  
may determine greater stroke severity in ICH, and thus prognosis [10]. More recent registry 
data reinforce the average greater severity of ICH compared to AIS and suggest association 
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of poorer prognosis to be independent of stroke type [11]. However, these comparisons may 
be similarly confounded by potential clinical bias in management strategies. 
 
We hypothesized that clinicians would exhibit negative perceptions of ICH compared to AIS 
by over-estimating the volume of brain lesions, assigning greater clinical severity and 
predicting poorer outcome based on acute CT appearances.  
 
 
Methods 
Study Design and Participants: 
This was a single center, retrospective, case-control study. Anonymized CT scans were 
selected from a local database of scans obtained from participants in observational or 
interventional research studies, where acute imaging was obtained. ICH cases presented 
between July 2013 and September 2016 and AIS cases between January 2009 and September 
2013. Oral anticoagulant-associated ICH cases were excluded. Ethical approval for the 
studies was given by national ethics committees and included participant consent for further 
imaging based research using de-identified scans.  The data that support the findings of this 
study are available from the corresponding author upon reasonable request. 
  
Group Characteristics:  
Clinical, demographic and stroke presentation characteristics were recorded for each 
participant. These included age, sex, past medical history and admission National institute of 
Health Stroke Scale (NIHSS) and estimated pre-stroke modified Rankin Scale (mRS) scores 
[12, 13].  
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Image Analysis: 
Whole brain non-contrast CT scans were acquired using either a Philips Brilliance 64 slice 
scanner, (120kV, slice thickness 0.6mm) or a General Electric optima scanner (120kV, slice 
thickness 0.6mm). Scans for the ICH cases were acquired <6h after onset of symptoms. AIS 
cases were also recruited <6h after symptom onset but follow-up imaging carried out at 
approximately 24 hours was used for comparison in this study to ensure sufficient time had 
passed to allow adequate visualization of the final infarct.  Scans were reviewed for presence 
or absence of intraventricular extension and ICH location (lobar or deep). ICH volumes were 
calculated by two techniques; the ABC/2 method [14, 15] using manual measurement of 
maximal ICH diameter in three perpendicular x, y and z planes on a 5mm thick slice of a 
multi-planar whole brain non-contrast CT image. Since the ABC/2 method assumes 
approximately ovoid geometry and may not estimate volume of irregularly shaped ICH 
accurately, we additionally undertook volumetric analysis using the imaging package MIStar 
(version 3.2.63) by manually placing a seed region of interest (ROI) in the hemorrhage on a 
single axial 5mm slice, followed by growing the ROI using automated thresholding then 
summation of multiple axial frames to derive a volume.  
 
For each scan, a single observer calculated lesion volumes twice, with a minimum interval of 
two weeks between the first and second measurements. The observer was blinded to first 
measurements at the time of second measurement. The mean of the two measurements was 
used as the lesion volume. Each of the ICH cases was matched with an AIS scan selected to 
be within ±10% of the volume of the ICH scan. Infarct volumes for the AIS comparators had 
been previously calculated using the same MIStar imaging package.  
 
Scan Review: 
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Scans were presented with no accompanying clinical information in a random order to 
clinicians of different levels of experience. Participants were asked to 1) estimate lesion 
volume to the nearest 5ml; 2) give a subjective impression of expected clinical severity on a 
scale of 1-5 (1 = mild, 5 = very severe); and 3) estimate 30-day prognosis by mRS (0-6).  
 
Statistical Analysis:  
Statistical analyses were performed using IBM SPSS Statistics version 21.0. Categorical 
variables are presented as frequencies and proportions and were compared using Pearson χ2 
test for association and Fisher’s Exact tests. Continuous variables are described as either 
mean (±standard deviation [SD]), or median (interquartile range [IQR]) and compared using 
independent samples t-test or Mann Whitney U tests for normally and non-normally 
distributed data respectively. Binary logistic regression analysis was carried out to assess 
factors (including stroke type, lesion volume, observer experience, patient age) predicting 
estimated favorable prognostic outcome (defined by mRS 0-2).  
 
 
Results 
Study participants and cohort characteristics 
Thirty-three CT scans were obtained for analysis as the ICH group, and were matched to 33 
AIS comparator CT scans from a local research imaging database. Comparison of clinical 
characteristics for the two groups (Table 1) showed higher median National Institutes of 
Health Stroke Scale (NIHSS) scores in the ICH group (17, IQR 10-21) compared to the AIS 
group (9, IQR 5-14, p=0.002). The level of consciousness component (NIHSS item 1a) was 
zero in most cases in both groups (19/33 ICH and 28/33 AIS). Atrial fibrillation (p=0.002) 
and hyperlipidemia (p=0.039) were more prevalent in the AIS group. 
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Scan review: 
A median of 8 (IQR 8-8.25) observers reviewed each scan. Forty-eight percent (n=16) of 
observers were experienced (14 stroke physicians, 2 neurologists) and 17 less experienced (5 
senior medical trainees, 7 junior medical trainees, 4 clinical research fellows, 1 stroke 
research nurse specialist).    
 
A median of 6 (IQR 5-7) volume estimations were made per scan. Thirteen scans from both 
the ICH and the AIS groups had ≤5 volume estimates. Mean measured lesion volume was the 
same for both groups: 25 ±30 ml for the ICH group and 26 ±32 ml for the AIS group (Figure 
1). Mean estimated lesion volume for ICH cases was significantly greater than for AIS cases 
(32 ±33ml compared to 17±23ml respectively, p<0.001). The mean difference between 
estimated and actual lesion volume was +8ml (±30) for the ICH group and -8ml (±27) for the 
AIS group (p<0.001, Figure 2). A sensitivity analysis found that there was no difference in 
volumes between scans that had ≤5 volume estimates when compared to scans with >5.  
 
There were 265 estimates of clinical severity and 30-day prognosis for the ICH group and 
257 for the AIS group. Clinicians graded ICH to be of greater severity than AIS (Figure 3) 
with estimates of greatest severity (categories 4 or 5) in 41% (n=109) of ICH case estimates 
compared to 14% (n=36) for AIS cases (p<0.001). Clinicians also estimated ICH cases to 
have less likelihood of favorable 30-day prognosis (defined as mRS 0-2) predicting 
independent recovery in 47% (n=125) of ICH cases compared to 74% (n=190) of AIS cases 
(Figure 4, p<0.001). Differences remained statistically significant for both analyses after 
omitting observers who did not make volume estimations.  
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In binary logistic regression, significant univariate predictors of estimated favorable outcome 
(mRS 0-2) were stroke type (ICH compared to AIS, odds ratio 0.31, 95% confidence interval 
0.19 - 0.48, p<0.001) and estimated lesion volume (odds ratio 0.56, 95% CI: 0.49 - 0.65, 
p<0.001). Observer experience (experienced compared to less experienced observers (odds 
ratio 1.83, 95% CI: 0.89 - 2.12, p=0.145) and patient age (odds ratio 1.07, 95% CI: 0.90 - 
1.29, p=0.443) were not. In multivariable logistic regression, predicted favorable outcome 
remained significantly associated with stroke type (odds ratio for ICH 0.47, 95% CI: 0.28 - 
0.80, p=0.005) after adjusting for estimated lesion volume.  
 
In exploratory analyses, we assessed whether radiological features that might have influenced 
observers modified the association of stroke type with estimated prognosis. Intraventricular 
hemorrhage (IVH) was present in 11 of 33 ICH cases (33%) but did not significantly 
influence estimated lesion volume or predicted outcome. Differences in volume estimations 
between AIS and ICH groups remained statistically significant after excluding cases with 
IVH. Presence of IVH was unrelated to either actual or estimated parenchymal ICH volumes: 
Comparing presence and absence of IVH cases, measured parenchymal ICH volumes were 
22ml and 27ml respectively (p=0.174) and estimated ICH volumes 30ml and 34ml (p=0.498). 
Forty-three percent (n=31) of IVH positive cases were predicted to have mRS 0-2 compared 
to 48% (n=93) of IVH negative cases (p=0.480). Median midline shift was 2.5mm in both 
ICH and AIS groups (Mann-Whitney U-test, p=0.658). Ventricular effacement of any degree 
was more commonly seen in ICH cases 19/33 cases versus 10/33, odds ratio 3.12, 95% CI 
1.13-8.60). Both midline shift and ventricular effacement were each associated with poorer 
estimated mRS outcomes. In a logistic regression analysis that included midline shift and 
ventricular effacement, stroke type remained significantly associated with reduced odds of 
favorable estimated 30 day mRS (OR 0.44, 95% CI 0.29-0.67, p<0.001). 
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There were 13 deep / basal ganglionic and 20 lobar ICH cases. Deep/ basal ganglionic ICHs 
were smaller than lobar ICH (17ml compared to 36ml, p<0.001). Estimated lesion volumes 
for both deep/basal ganglionic bleeds and lobar bleeds were significantly greater than 
measured volumes (22ml and 46ml respectively, p<0.001 for each). Sixty percent (n=86) of 
deep/basal ganglionic bleeds were estimated to have a favorable 30 day prognosis compared 
to 31% (n=38) of lobar ICH cases (p<0.001).  
 
 
Discussion 
Using CT scans matched for lesion volume, we found that clinicians significantly 
overestimated the volume of ICH, and underestimated the volume of AIS. In addition, 
clinicians estimated clinical severity to be significantly greater for ICH, and predicted less 
likelihood of favorable day 30 outcomes for ICH compared to AIS, even after adjusting for 
estimated lesion volume, and independent of radiological features including midline shift, 
and ventricular effacement.  
  
Intraventricular hemorrhage is associated with greater ICH severity [16-18], and was present 
in a third of our ICH cases but did not appear to influence clinicians’ interpretation of 
volume, severity or prognosis. 
 
Limitations of this study include its small sample size and its single center, retrospective 
design. We did not match cases for imaging features denoting “brain frailty”, such as the 
presence of brain atrophy, established cerebrovascular lesions or small vessel disease [19, 20] 
that may have impacted clinicians’ estimates; however, patient age (as a surrogate for brain 
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frailty measures) did not modify the significant differences between ICH and AIS in 
estimated prognosis. While we selected control cases on the basis of lesion volume, location 
may also be relevant to both prognosis and severity, and was not matched across the study 
groups [21, 22]. Similarly, we were not able to account for other factors of prognostic 
relevance such as hematoma location, intraventricular hemorrhage, hematoma density and 
morphology, [23-27] which often have no correlate in AIS cases. Additionally, a single 
baseline CT cannot capture the dynamic nature of ICH, the hematoma expansion commonly 
seen in the early hours after onset signifying poorer prognosis [28-30]. 
 
A greater propensity for deep location of ICH compared to AIS with internal capsular 
involvement could have accounted for the higher median NIHSS scores in ICH cases, since 
motor function represents a higher proportion of scores than other aspects of neurological 
deficit [12].  Level of consciousness accounted for only a small proportion of total NIHSS 
score in both groups. It is possible that observers may have taken lesion location into account 
when making prognostic estimations, but this could not be included in our analysis since the 
inherently different pathologies make matching of both volume and location for ICH cases 
with equivalent AIS cases extremely challenging. Lobar hemorrhages were estimated to have 
poorer 30-day prognosis compared to deep/basal ganglionic ICH, but lobar ICHs were 
significantly larger, therefore volume is likely to be the dominant factor considered by 
clinicians.  
 
Our results suggest that a bias is present among clinicians in assessing stroke severity and 
prognosis for ICH compared to AIS. This may be of importance since outcomes are 
significantly affected by acute management, including end-of-life decisions or delays in 
secondary preventative treatment or rehabilitation [31-33].  
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Figure Legends 
Table 1: Cohort characteristics for study participants according to stroke type. AIS denotes 
acute ischemic stroke, ICH intracerebral hemorrhage, SD standard deviation, NIHSS 
National Institutes of Health Stroke Scale, IQR interquartile range, mRS modified Rankin 
Scale, TIA transient ischemic attack  
 
Figure 1: Scatter plot showing actual against estimated lesion volume for acute ischemic 
stroke (AIS), and intracerebral hemorrhage (ICH) cases. Each point represents an individual 
case. Solid lines represent the line of best fit for average estimation for a given volume. 
Dotted lines represent 95% confidence intervals for average estimation for a given volume.  
 
Figure 2: Individual value plot highlighting difference between estimated and actual lesion 
volumes for the acute ischemic stroke (AIS), and intracerebral hemorrhage (ICH) cases. 
Each point represents an individual case. 
 
Figure 3: Stacked bar chart illustrating distribution of severity estimations for acute ischemic 
stroke (AIS), and intracerebral hemorrhage (ICH) cases.  Figures in each category denote n 
(%). 
 
Figure 4: Stacked bar chart illustrating distribution of 30-day prognosis estimations on the 
modified Rankin Scale (mRS) for acute ischemic stroke (AIS), and intracerebral hemorrhage 
(ICH). Figures in each category denote n (%).  
 
Tables 
Table 1: Cohort characteristics for study participants according to stroke type 
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Statistical Tests: * 2-sample t-test, † Chi-squared test of association with continuity 
correction, ‡ Mann Whitney test, § Fisher’s exact test  
Characteristics 
 
AIS   
participants  
(n=33) 
ICH 
participants 
(n=33) 
P value 
Lesion Volume (ml), Mean 
(±SD) 
26 (±31.9) 25 (±30.2) 0.885* 
Age (years), Mean (±SD)  66 (54-78) 69 (55-83) 0.409* 
Male sex, n (%) 23 (70%) 19 (58%) 0.443† 
Smoker, n (%) 14 (42%) 13 (39%) 1.00† 
Baseline NIHSS, Median (IQR) 9 (5-14) 17 (10-21) 0.002‡ 
Underwent thrombolytic 
treatment, n (%) 
31 (94%) 0 (0%) <0.001† 
Pre-stroke mRS 
     0 
     1 
     2 
     3 
     >3 
     Not Provided 
 
29 (88%) 
1 (3%) 
1 (3%) 
1 (3%) 
0 (0%) 
1 (3%) 
 
25 (76%) 
1 (3%) 
3 (9%) 
4 (12%) 
0 (0%) 
0 (0%) 
 
 
 
 
0.379§ 
Past Medical History     
     Hypertension, n (%) 16 (48%) 21 (64%) 0.321† 
     Diabetes Mellitus, n (%) 5 (15%) 6 (18%) 1.00† 
     Ischemic heart disease, n (%)  6 (18%) 4 (12%) 0.144§ 
     Atrial Fibrillation, n (%) 9 (27%) 0 (0%) 0.002† 
     Hyperlipidemia, n (%) 16 (48.5%) 7 (21%) 0.039 † 
     AIS or TIA, n (%) 4 (12%) 4 (12%) 1.00§ 
     Antiplatelet therapy, n (%) 14 (42%) 9 (27%) 0.301 † 
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Figures 
 
Figure 1: Actual against estimated lesion volume for AIS and ICH  
 
Figure 2: Difference between estimated and actual lesion volumes for AIS and ICH 
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Figure 3: Distribution of severity estimations for AIS and ICH 
 
 
Figure 4: Distribution of 30-day prognostic estimations on the mRS for AIS and ICH 
 
